The offer values the shares in Dignitana at a total of approximately SEK 153.0 million.

“Paxman and Dignitana have developed a strong relationship over the past few years, and it is clear that we share a very common vision. With the strength of both companies, we are well positioned to achieve that vision in a faster and more meaningful way. There is a clear synergistic value and strength to be gained through the merger of these two fine companies, and we look forward to this strengthened position as we enter a period of exciting changes in the reimbursement landscape in the USA. Change is, of course, inevitable but for the better, ensuring that we have the right resources for the next chapter in our growth story,” says Richard Paxman, CEO of Paxman.

Dignitana’s Board of Directors unanimously recommends the shareholders to accept the offer

Dignitana’s Board of Directors unanimously recommends Dignitana’s shareholders to accept the offer. Agartha AB, which controls approximately 29.8 per cent of the total number of outstanding shares and votes in Dignitana, supports and has undertaken to accept the offer.

The acceptance period for the offer is expected to commence on or around 14 April 2025 and end on or around 5 May 2025, with payment of consideration expected to be made on or around 13 May 2025.

Paxman and Dignitana

As of 31 December 2024, Paxman had 105 employees, principally in the UK and the US, and Dignitana had 26 employees, principally in Sweden and the US. Paxman will conduct a thorough review of both companies to capitalize on the synergies and economies of scale that a merger is expected to bring. Changes resulting from the offer that pertain to Dignitana’s employees or regarding employment and operations at the locations where Paxman and Dignitana conduct their business will need to be examined more closely, the company states. Any measures to be implemented in connection with the integration will be determined following the completion of a detailed review of the combined business in the period following completion of the offer, states Paxman.

Paxman’s and Dignitana’s shares are traded on Nasdaq First North Growth Market.